Login / Signup

Comparison of various strategies to define the optimal target population for liver fibrosis screening: A population-based cohort study.

Fredrik O ÅbergAntti JulaMartti A FärkkiläVeikko V SalomaaIris ErlundSatu MännistöTerhi VihervaaraMarkus PerolaAnnamari LundqvistVille Männistö
Published in: United European gastroenterology journal (2022)
Compared to previously reported traditional risk factor-based strategies, use of the CLivD captured substantially more cases with advanced liver disease in the population and may be superior for targeting further fibrosis screening.
Keyphrases
  • liver fibrosis
  • risk factors
  • cancer therapy